FDA Maintains Pressure Against Adulterated ED Supplements
This article was originally published in The Tan Sheet
Executive Summary
FDA says its seizure of $74,000 in mislabeled erectile dysfunction supplements from SEI Pharmaceuticals July 24 demonstrates the steps the agency will take when a company fails to heed a warning about an allegedly adulterated product
You may also be interested in...
Libimax supplement a bit too potent
Nature & Health Co. announces a recall of its male enhancement formula after FDA analysis found samples of Libimax contained tadalafil, the active ingredient in Eli Lilly's Rx erectile dysfunction drug Cialis. FDA warns that tadalafil, in conjunction with nitrates found in prescription cholesterol drugs, can cause a dangerous drop in blood pressure. Brea, Calif.-based Nature & Health said April 27 the recalled product was sold in retail stores in California, Georgia, Illinois, Ohio and Texas. FDA has emphasized it will seize adulterated supplement products when firms fail to comply with recall requests (1"The Tan Sheet" July 28, 2008, p. 15)
Threat Of Adulteration For Profit Grows With Globalization Of Supply Chain
Deliberate adulteration of dietary supplements for economic gain is a growing threat that FDA and the food and drug industries must work together to neutralize, according to the agency's food safety chief and a trade group executive
Hi-Tech Prosecution Offers FDA Model For Pursuing Bad Actors – Lawyer
The successful prosecution of Hi-Tech Pharmaceuticals for counterfeiting generic Rx drugs should encourage FDA to pursue criminal charges against other companies selling adulterated products, according to food and drug attorney Marc Ullman